References
- Roy DA, Schaefer U, Guetta V, et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol. 2013;61:1577–1584. 10.1016/j.jacc.2013.01.018.
- Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology, and the European Association for Cardio-Thoracic-Surgery. Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451–2496. 10.1093/eurheartj/ehs109.
- Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:e57–185. 10.1016/j.jacc.2014.02.536.
- Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70:252–289. 10.1016/j.jacc.2017.03.011.
- Abdelghani M, Cavalcante R, Miyazaki Y, et al. Transcatheter aortic valve implantation for mixed versus pure stenotic aortic valve disease. EuroIntervention. 2017 Jul 11. pii:EIJ-D-17-00328. doi: 10.4244/EIJ-D-17-00328. [Epub ahead of print].